Cargando…

Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach

Detalles Bibliográficos
Autores principales: López-Viña, Antolín, Diaz Campos, Rocio M., Trisan Alonso, Andrea, Melero Moreno, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872189/
https://www.ncbi.nlm.nih.gov/pubmed/36704752
http://dx.doi.org/10.3389/falgy.2022.1119941
_version_ 1784877351425802240
author López-Viña, Antolín
Diaz Campos, Rocio M.
Trisan Alonso, Andrea
Melero Moreno, Carlos
author_facet López-Viña, Antolín
Diaz Campos, Rocio M.
Trisan Alonso, Andrea
Melero Moreno, Carlos
author_sort López-Viña, Antolín
collection PubMed
description
format Online
Article
Text
id pubmed-9872189
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98721892023-01-25 Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach López-Viña, Antolín Diaz Campos, Rocio M. Trisan Alonso, Andrea Melero Moreno, Carlos Front Allergy Allergy Frontiers Media S.A. 2023-01-10 /pmc/articles/PMC9872189/ /pubmed/36704752 http://dx.doi.org/10.3389/falgy.2022.1119941 Text en © 2023 López-Viña, Díaz Campos, Trisan Alonso and Melero Moreno. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Allergy
López-Viña, Antolín
Diaz Campos, Rocio M.
Trisan Alonso, Andrea
Melero Moreno, Carlos
Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
title Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
title_full Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
title_fullStr Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
title_full_unstemmed Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
title_short Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
title_sort corrigendum: uncontrolled severe t2 asthma: which biological to choose? a biomarker-based approach
topic Allergy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872189/
https://www.ncbi.nlm.nih.gov/pubmed/36704752
http://dx.doi.org/10.3389/falgy.2022.1119941
work_keys_str_mv AT lopezvinaantolin corrigendumuncontrolledseveret2asthmawhichbiologicaltochooseabiomarkerbasedapproach
AT diazcamposrociom corrigendumuncontrolledseveret2asthmawhichbiologicaltochooseabiomarkerbasedapproach
AT trisanalonsoandrea corrigendumuncontrolledseveret2asthmawhichbiologicaltochooseabiomarkerbasedapproach
AT meleromorenocarlos corrigendumuncontrolledseveret2asthmawhichbiologicaltochooseabiomarkerbasedapproach